SeaStar Medical Holding Corp

SeaStar Medical Holding Corporation (Nasdaq: LMAO) is a post-merger medical device company that traces its public-markets debut to LMF Acquisition Opportunities, Inc., a blank-check vehicle sponsored by LM Funding America that completed its IPO in 2021. The SPAC closed its business combination with SeaStar Medical, Inc. in October 2022, creating a combined entity focused on developing the Selective Cytopheretic Device, a therapy targeting systemic inflammation and acute organ injury. The company filed an 8-K with the SEC on March 21, 2025. For comprehensive filing histories, sponsor profiles, and real-time SPAC analytics on SeaStar Medical and the broader SPAC universe, sign up for full data access at SpacDesk.